DOCSLIB.ORG

Audrey's Picks List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Audrey's Picks List Audrey’s Life Science Meeting Picks for October-November 2010 Complimentary Service of AudreysNetwork.com (Oct. 9, 2010 Edition) *********************************************************** Bio2DeviceGroup, Tuesday Evening, Tuesday, Oct. 12, 2010 Topic: “Gene Therapy: The Next Generation Cancer Therapy” Speaker: Jeff Galvin, CEO, American Gene Technologies Date and Time: Tuesday Evening, Oct. 12, 2010 Location: Wilson Sonsini Goodrich & Rosati-- 650 Page Mill Road, Palo Alto , CA 94306 Register at www.bio2devicegroup.org week prior to meeting Cost: $6 - Students/In-transition - Members only $11 - Early-bird Registration - Members only $20 - Late Registration and Non-Members $25 - Walk-ins Topic Description Jeff will speak about the work of his company American Gene Technologies (AGTII) in developing potentially improved cancer therapies with higher efficacy than currently available drug treatments. AGTII was founded in 2007 to develop bio-safe, high- efficiency, multi-gene vectors for human gene delivery, in-vivo. AGTII’s products provide a method for the clinical delivery of gene therapy for the treatment of cancers, autosomal disorders, stem cell therapies, and cosmetic applications. Speaker Bio Jeffrey A. Galvin, CEO, Inventor, and Co-Founder of AGTII earned his degree in economics from Harvard College in 1981. He has over 30 years of business and entrepreneurial experience in Silicon Valley including founder or executive positions at several startups that were taken public and/or sold to public companies -- including a company that provided the market-dominant quality control software for linear accelerators in cancer clinics which was sold to Varian, Inc (NYSE:VAR). In 2007 Mr. Galvin founded an angel investment company which provided the startup capital for AGTII. ******************************************************** Deloitte Recap’s Free Webinar, Tuesday Morning, Oct. 12, 2010 Topic: “Development and Commercialization Diligence in Biopharma Alliances” Join Recap's free, live webinar Date and Time: October 12, 2010,10:00-11:00 AM Pacific / 1:00-2:00 PM Eastern Register to attend today! http://www.recap.com/882575E5007F1AA1/w_WebinarReg?OpenForm&U=502ED6EA81 87E6CF88257752000BEBC1 Topic Description Is there more to development and commercialization diligence in biopharma alliances than "use reasonable efforts"? Should there be? Join us on October 12 to explore this issue. The business terms of biopharma alliances have changed substantially over the past decade with respect to financial payments, risk sharing and dev elopment options. However, the diligence standards for clinical development, regulatory approval and commercialization are generally unchanged when big pharma is the licensee, and only occasionally more specific when specialty pharma in-licenses a compound. As more products come to market through alliances, should there be a tightening of performance requirements with respect to: Clinical development timetables Development expenditures Minimum annual sales Commercial expenditures We will survey recent biopharma alliances, describe and discuss novel approaches, and debate the merits and drawbacks of such provisions. Who should attend: Business development Biopharma corporate executives VCs and investment banks CFOs and financial executives Legal Can't attend live? Register to receive the recorded webinar and accompanying slides. ******************************************************** SF AWIS, Wednesday Evening, Oct. 13, 2010 Event: “Social Networking” Date and Time: Wednesday, October 13th, 2010 Location: Bissap Baobab, 2323 Mission Street, San Francisco, COST: FREE All professionals in the sciences, students, and friends are welcome. For additional information check http://www.sfawis.com/ ******************************************************************* NorCal BioPharmaPM, Thursday Evening, Oct. 14, 2010 Topic: "Perspectives on the Practice of Project Management in Biotechnology over the Last 15 years" Speakers: Rajendra Mohabir, Ph.D and Timothy Yang, PMP Date: Thursday October 14, 2010, 6:00-9:30 PM Agenda 6:00 pm - 7:00 pm Networking 7:00 pm - 8:00 pm Dinner 8:00 pm - 9:30 pm Presentation Location: Hilton Garden Inn MAP, 670 Gateway Boulevard, South San Francisco Cost: $45 (+ nominal service fee), please RSVP on Eventbrite to register Topic Description Please join us for an interactive discussion to share best industry practices for Project Management in Biotechnology. The keynote speakers have 40 years of combined experience in instituting Project Management Offices and refining the practice of Project Management from early to commercial development of global programs. The presenters will speak about the following topics, and offer counter perspectives to: Team Models Roles and Responsibilities Necessary Background for a Successful Project Manager Value of Project Management Cuisine Offerings Networking Beverage Service - Complimentary sodas, bottled water, juices, iced tea, and coffee & tea - Cash bar service Buffet Dinner Service Speaker Bios Raj Mohabir has 20 years of industry experience. He started off his career as a Staff Scientist at Syntex Discovery Research. He then held roles of increasing responsibility in project management/team leadership at Roche in Palo Alto, Genentech and Amgen. He also had expanded management responsibility at Amgen where he was Head of Oncology Project Management. He returned to Roche Palo Alto in 2008, where he was Site Head for Global Project Management. In Q3 2009, he returned to Genentech, where he is currently the Head of Project Management for Genentech Research and Early Development. Raj has a Bachelor’s degree in Microbiology and Immunology from McGill University, a Ph.D. in Pharmacology from Dalhousie University, and completed post-doctoral training in Cardiology at Stanford University School of Medicine. Tim Yang has worked at Genentech, Inc. for 19 years across multiple functions including Manufacturing, Clinical Research, Commercial and Product Development/Project Management. His current role is as an Associate Director in the Portfolio Management and Operations group, primarily supervising Project Managers. Tim holds a Bachelor’s degree in Evolutionary Biology with a minor in Music Theory and Performance from UC Santa Cruz, and a Master’s degree in Public Administration from the University of San Francisco. He is also PMP certified. Registration Please RSVP on Eventbrite to secure your reservation. Cash, check or credit cards will be accepted (cash and checks, please tender in person or by mail). Payments must be received by October 12th. *************************************************** Golden Gate Polymer Forum, Thursday, Oct. 14, 2010 Topic: "Nanobreadboards and Self-Organizing Polymers: An Introduction to (Synthetic) DNA Nanotechnology" Speaker: Rebecca Schulman, Miller Fellow, Department of Physics, University of California, Berkeley,http://www.rschulman.org Date and Time:Thursday, Oct. 14, 6:00 PM social hour, 7:00 PM dinner, 8:00 PM presentation Location: Michael's Restaurant at Shoreline Park, Mountain View (directions below) Dinner Selections: Salmon filet with beurre blanc Chicken Marsala Eggplant Parmigiana Cost: Employed/postdocs: $35 normal registration Unemployed/retired/students: $20 normal registration After deadline: registration not guaranteed, so contact us late fee applies -- $40 regular/employed, $25 unemployed/student/retired Free if you attend just the lectures at 8:00 PM (but please let us know for headcount) Deadlines for registration: Advance registration ends 5pm Wed. Oct 6. Regular registration ends 5pm Wed. Oct 13. Because we must pay the restaurant for the ordered meal, we must ask no- shows to pay for their reservation. However, penalty-free cancellations are allowed up until the deadline for reservations the day before the event. Location: Address: 2960 N Shoreline Blvd. PLEASE NOTE: we accept cash or checks, but are unable to accept payment by credit card at this time. You may pay at the door. Please register on the web page www.GGPF.org Topic Description Biology self-assembles structures with nanoscale precision that can grow, adapt to their environment, and even self-replicate. These complex behaviors are the result of complex networks of chemical reactions consisting of hundreds or even thousands of proteins, lipids, and nucleic acids with particular concentrations and reaction rates. While building synthetic networks is still out of reach, we can explore complex self- assembly using synthetic DNA. DNA's well-understood chemistry and sequence-specific chemical interfaces allow us to "program" self-assembly reactions with many components that yield predictable results. Dynamic cascades of reactions can be organized by building metastable structures and controlling access to catalysts and molecular fuel that can drive changes in form. We can use DNA to build not just double helices, but branched 2- and 3-dimensional structures, nanotubes, and other polymers shapes. These structures can serve as "nanobreadboards" with complex patterns that can serve as templates for nanoparticles or proteins. Further, we can start to think about assembling these structures in complex geometries. As an example, I'll talk about building scaffolds for self-guiding wires, i.e. the self-assembly of nanotubes between two terminals where the locations of the end points are uncertain. ************************************************************ Fogarty Lecture, Friday Afternoon, Oct. 15, 2010 Topic: “Have We Reached the
Load more

Recommended publications
  • Advanced Management and Protection of Energy-Storage Devices
    Advanced Management and Protection of Energy-storage Devices (AMPED) Teaming List This document contains the list of potential teaming partners for the Advanced Management and Protection of Energy-storage Devices (AMPED), solicited in DE-FOA-0000675 Funding Opportunity Announcement (FOA) and is published on ARPA-E eXCHANGE (https://arpa-e-foa.energy.gov), ARPA-E’s online application portal. This list will periodically undergo an (Updated: April 4, 2012) update as organizations request to be added to this teaming list, and will stop updating once the AMPED FOA DE-FOA-0000675 closes. If you wish for your organization to be added to this list please refer to https://arpa-e-foa.energy.gov/ for instructions, or follow https://arpa-e-foa.energy.gov/FileContent.aspx?FileID=990f3d40-a651-4e97-8676-2201981e48a4 to the specific announcement. Organization Name Contact Name Contact Address Contact E-mail Contact Phone Organization Type Focus Areas Capabilities A123 Systems Dr. Mike Marcel, P.E. 39000 7 Mile Road, Livonia, MI 48152 [email protected] (734) 772-0587 Publicly Held company Energy Storage (High Volume A123 Systems, with corporate headquarters in Watertown, MA, employs over 2000 employees in multiple locations worldwide. They occupy over manufacturing, Research and 1,000,000 square foot of manufacturing facilities in the United States (Massachusetts and Michigan) to include the largest cell manufacturing facility Development of Li-Ion Batteries) in Livonia, MI. A123 is currently underway expanding its capability in Michigan with more manufacturing capability in Livonia, MI and a Powder coating facility in Romulus, MI. A123 employs one of the largest lithium battery development teams in the country.
    [Show full text]
  • Past CONNECTIONS™ Speaker List
    Hosted By 2019 KEYNOTES Jacob Atalla, VP, Sustainability, KB Home Charlie Kindel, Senior Vice President, Products and Services, Anne Ferguson, Vice President of Marketing, Alarm.com Control4 Chris Jones, Chief Technology Officer, iRobot Dennis Mathew, Vice President and General Manager, Xfinity Home, Comcast David Kaiserman, President, Lennar Ventures, Lennar Jeremy Warren, CTO, Vivint Smart Home SPEAKERS Ashish Aggarwal, Co-Founder & CTO, Caavo Drew Doleski, Senior Product Manager - IoT, Connected Marcio Avillez, SVP of Business Development, CUJO AI Home, Verisk Analytics Avi Barel, Director, Business Development, ULE Alliance Kristi Ebong, SVP of Strategy and GM, Orbita, Inc. Christopher Baskin, CEO, American Two-Way Aaron Emigh, CEO and Founder, Brilliant Frederic Bastien, Co-founder and CEO, Mnubo Stephen Eyre, Area Vice President, Cloud & Smart Home and Business Solutions, Calix Justin Berghoff, Director, Business Development & Product Management, Residential, Leviton Manufacturing Co., Inc. Mel Fox, Product Owner, Nexia Home, Residential HVAC & Supply, Ingersoll Rand Greg Berkin, Managing Director, Concours Ventures Tony Frangiosa, CEO, InstallerNet, Inc. Dan Berte, Director, IoT, Bitdefender David Friedman, Co-Founder, Executive Chairman, & Chief Yuval Boger, CMO, Wi-Charge Strategy Officer, Ayla Brian Brackenbury, Director, Connected Products, Gentex Axel Fuchs, Partner, Motus Ventures Corporation Jan-Philipp Gehrmann, Director, Head of Automotive Sales & Alex Capecelatro, CEO, Josh.ai Marketing Silicon Valley, NXP Joseph Carangelo, Executive Director, Strategy and Chris Gibbons, MD, Founder and CEO, The Greystone Group, Innovation, Baker Electric Home Energy Inc. Chris Carney, CEO & Co-Founder, Abode Cristene Gonzalez-Wertz, Electronics + Environment, Energy & Thar Casey, CEO, Amber Solutions, Inc. Utilities Research Director, IBM Institute for Business Value Andy Chambers, Vice President of Connected Home, Assurant Todd Grantham, Chief Marketing Officer, Plume Design Inc.
    [Show full text]
  • People Power Pro Energy
    our business partners drive scale with delightful People Power experiences for them and their customers, Pro Energy 2.0 People Power Pro Energy 2.0 includes: > Energy services made intelligent Sophisticated demand response services with AI enabled energy-centric customizable microservices to address key consumer opportunities at scale. Adding industry- > Device integration for the masses Deliver intelligence to an array of devices for targeted leading artificial energy programs with thermostats, home lighting, intelligence for vastly improved load controllers, plugs, switches and more. smart home experiences, > Management of IoT made easy Energy efficiency and IoT initiatives are elegantly delivered People Power Pro Energy 2.0 and managed by service providers with People Power’s provides critical breakthroughs improved command center – Maestro 2.0. in AI device and service integration Energy Intelligence for white-label IoT deployments. Leading the industry in AI development for IoT, People Power has created patent pending, energy- The Modern Approach centric services for the smart home that meet the Today’s home is capable of moving to a new level of needs of both energy providers and consumers. energy efficiency and intelligent connectedness – Each new service is configured with AI-enabled going beyond basic demand response and thermostat microservices to deliver modular functionality for control. Energy service providers can now offer highly optimal intelligence and performance. By learning key valued consumer services using innovative artificial activities and patterns in the home, configurations of intelligence (AI) technology with People Power Pro microservices help any service understand when to Energy 2.0. It’s the most advanced solution for optimize energy consumption to maximize comfort, scalable market deployments to maximize energy convenience and energy savings.
    [Show full text]
  • Annual Report 2017 Contents
    Annual report 2017 Contents To our shareholders 1 Combined review of operations 17 At a glance 2 1.1 Strategy 18 Letter from the CEO 3 1.2 Innovation 26 Executive Board 4 1.3 Energy sector environment 32 Supervisory Board report 6 1.4 Political environment 36 innogy stock 12 1.5 Major events 41 1.6 Reporting principles 48 1.7 Business performance 51 1.8 Financial position and net worth 66 1.9 Notes to the financial statements of innogy SE 73 1.10 Disclosure relating to German takeover law 78 1.11 Compensation report 81 1.12 Opportunities and risks 98 1.13 Outlook 107 2 Responsibility statement 111 3 Consolidated financial statements 113 3.1 Income statement 114 3.2 Statement of comprehensive income 115 3.3 Balance sheet 116 3.4 Cash flow statement 117 3.5 Statement of changes in equity 118 3.6 Notes 119 3.7 List of shareholdings (part of the notes) 184 3.8 Boards (part of the notes) 211 3.9 Independent auditor’s report 216 Further information Information on the auditor 223 Five-year overview 224 Legal disclaimer 225 Imprint 226 Financial calendar At a glance innogy Group 2017 2016 +/– % Power generation from renewable sources billion kWh 10.2 10.0 2.0 External electricity sales volume billion kWh 262.4 242.5 8.2 External gas sales volume billion kWh 227.5 241.3 − 5.7 External revenue € million 43,139 43,611 − 1.1 Adjusted EBITDA € million 4,331 4,203 3.0 Adjusted EBIT € million 2,816 2,735 3.0 Income before tax € million 1,648 2,201 − 25.1 Net income/income attributable to innogy SE shareholders € million 778 1,513 − 48.6 Adjusted net
    [Show full text]
  • Farha Chowdry
    Farha Chowdry Partner T: +1.650.815.2662 379 Lytton Avenue F: +1.650.815.4672 Palo Alto, CA 94301 [email protected] Farha Chowdry is a partner in the Corporate Practice Group in the firm’s Palo Alto and San Diego (Del Mar) offices. Areas of Practice Farha has extensive experience in general corporate transactional matters. She works with emerging growth companies through all stages of their lifecycle and venture capital funds in their negotiation, structuring and maintenance of portfolio company investments. Farha also represents clients in complex merger and acquisition transactions. She routinely advises clients in both acquisitions and dispositions of companies and lines of business. Farha represents clients in a broad range of industries, including software, internet games/ social media, eCommerce and healthcare. Experience Representative Private Company Financing Transactions ■ Represented Signet Healthcare Partners in connection with various portfolio company investments. ■ Represented Extend, Inc., a provider of tailored protection plans for products across almost any industry, in its Series Seed, Series A and Series B Preferred Stock financings. ■ Represented HealthLoop, a cloud-based platform that automates follow-up care, in connection with its Series A Preferred Stock financing. ■ Represented XL Innovate in connection with various portfolio company investments. ■ Represented Spotter, Inc., a provider of financial solutions for independent content creators across digital platforms, in its Series A and Series B Preferred Stock financings. ■ Represented the creator of a real-time job skills trading platform in connection with its Series Seed Preferred Stock financing with investments from venture capital firms and angel investors. ■ Represented Lex Machina, a SAAS provider of data analytics for patent and trademark litigation data, in connection with its Series A Preferred Stock financing.
    [Show full text]
  • Audrey's Life Science Meeting Picks for October-November 2010
    Audrey’s Life Science Meeting Picks for October-November 2010 Complimentary Service of AudreysNetwork.com (Oct. 2, 2010 Edition) *********************************************************** Bio2Device Group, Tuesday Morning, Oct. 5, 2010 Topic: “RoadMAP to Leadership – How to Develop and Train in a Small Biotech Environment” Speaker: Marco F. Rosa, Vice President of Human Resources, MAP Pharmaceuticals, Inc. Date and Time: Tuesday, Oct. 5, 2010, 8:30 – 10:30 am Location: Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA (across the street from Sunnyvale Public Library) Cost: Free Street and in NOVA and library parking lots across the street. Topic Description How do a small to medium sized /biotech/med-device companies infuse learning and development programs for key managers/directors and influence the executive team to fund this new program in light of cost constraints and budget cuts. How can HR make it happen and the by-product culminating in the Executive Team wanting to desperately join and be a “willing and instructional participant?” Speaker Bio Mr. Rosa brings over 20 years of human resources experience and joined MAP Pharmaceuticals in May 2008 as Vice President of Human Resources. Prior, Mr. Rosa worked at Carl Zeiss Meditec, Inc. as Vice President of Worldwide Human Resources, a position he had held since May of 2002. He was an integral part of the senior management team overseeing the company's growth and the commercial launch of several ophthalmology and surgical microscopy devices. In addition, Mr. Rosa served as Vice President, Human Resources at COR Therapeutics, Inc. (Millennium Pharmaceuticals), building the development and commercial organization that launched Integrilin® into the cardiovascular angioplasty market.
    [Show full text]
  • China Digital Video Holdings Limited 中國數字視頻控股有限公司
    CHINA DIGITAL VIDEO HOLDINGS LIMITED CHINA DIGITAL 中國數字視頻控股有限公司 CHINA DIGITAL VIDEO HOLDINGS LIMITED 中國數字視頻控股有限公司 CHINA DIGITAL VIDEO HOLDINGS LIMITED 中國數字視頻控股有限公司 Dreamwork_cover_A20_21_5mmOL.indd 2 10/6/2016 上午10:35 IMPORTANT IMPORTANT: If you are in any doubt about any of the contents of this prospectus, you should seek independent professional advice. China Digital Video Holdings Limited 中國數字視頻控股有限公司 (incorporated in the Cayman Islands with limited liability) LISTING ON THE GROWTH ENTERPRISE MARKET OF THE STOCK EXCHANGE OF HONG KONG LIMITED BY WAY OF GLOBAL OFFERING Number of Offer Shares under the : 155,000,000 Shares (subject to the Global Offering Over-allotment Option) Number of Hong Kong Offer Shares : 15,500,000 Shares (subject to reallocation) Number of International Offer Shares : 139,500,000 Shares (subject to reallocation and the Over-allotment Option) Maximum Offer Price : HK$2.57 per Offer Share, plus brokerage of 1%, SFC transaction levy of 0.0027% and Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong dollars and subject to refund) Nominal Value : US$0.00001 per Share Stock Code : 8280 Sole Sponsor Sole Global Coordinator Joint Bookrunners Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this prospectus, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this prospectus. A copy of this prospectus, together with the documents specified under the section headed “Appendix V—Documents Delivered to the Registrar of Companies and Available for Inspection” to this prospectus, has been registered by the Registrar of Companies in Hong Kong as required by section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong).
    [Show full text]